Gene · 8295
Papers1,639
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,639
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sedoheptulose Kinase SHPK Expression in Glioblastoma: Emerging Role of the Nonoxidative Pentose Phosphate Pathway in Tumor Proliferation. | Int J Mol Sci | 2022 | 35682658 | PubTator, text mining | PubMed |
| Longitudinal genomic alternations and clonal dynamics analysis of primary malignant melanoma of the esophagus. | Neoplasia | 2022 | 35661532 | PubTator, text mining | PubMed |
| Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial. | Int J Mol Sci | 2022 | 35628499 | PubTator, text mining | PubMed |
| Nuclear Receptor Coregulators in Hormone-Dependent Cancers. | Cancers (Basel) | 2022 | 35626007 | PubTator, text mining | PubMed |
| Genome-wide sequencing and the clinical diagnosis of genetic disease: The CAUSES study. | HGG Adv | 2022 | 35599849 | PubTator, text mining | PubMed |
| Breast cancer risks associated with missense variants in breast cancer susceptibility genes. | Genome Med | 2022 | 35585550 | PubTator, text mining | PubMed |
| A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients. | Cancers (Basel) | 2022 | 35565241 | PubTator, text mining | PubMed |
| No-nonsense: insights into the functional interplay of nonsense-mediated mRNA decay factors. | Biochem J | 2022 | 35551602 | PubTator, text mining | PubMed |
| The Impact of lncRNA on Diabetic Kidney Disease: Systematic Review and In Silico Analyses. | Comput Intell Neurosci | 2022 | 35528328 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing in silent corticotroph tumors confirms impaired POMC processing and provides new insights into their invasive behavior. | Eur J Endocrinol | 2022 | 35521707 | PubTator, text mining | PubMed |
| Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian. | Cancer Cell Int | 2022 | 35488336 | PubTator, text mining | PubMed |
| Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status. | BMC Med | 2022 | 35484593 | PubTator, text mining | PubMed |
| Study on the Interaction between Serum Thyrotropin and Semen Parameters in Men. | Med Sci (Basel) | 2022 | 35466230 | PubTator, text mining | PubMed |
| Recent Advances in Synergistic Antitumor Effects Exploited from the Inhibition of Ataxia Telangiectasia and RAD3-Related Protein Kinase (ATR). | Molecules | 2022 | 35458687 | PubTator, text mining | PubMed |
| Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy. | Int J Mol Sci | 2022 | 35457081 | PubTator, text mining | PubMed |
| Neuroepigenetic Mechanisms of Action of Ultrashort Peptides in Alzheimer's Disease. | Int J Mol Sci | 2022 | 35457077 | PubTator, text mining | PubMed |
| Lysine methyltransferase inhibitors: where we are now. | RSC Chem Biol | 2022 | 35441141 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor. | Mol Cancer Ther | 2022 | 35439318 | PubTator, text mining | PubMed |
| Precision Combination Therapies Based on Recurrent Oncogenic Coalterations. | Cancer Discov | 2022 | 35412613 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8295/papers?page=14